Why the study?
Is adiponectin associated with cardiovascular risk factors and vascular outcomes in type 1 diabetic patients?
Population
543 type 1 diabetic patients from the EURODIAB Prospective Complications Study
Design
Cross-sectional
Authors
Loading...
Adiponectin may mark vascular complications in type 1 diabetes; leaves open causal role or therapeutic targeting.
Is adiponectin associated with cardiovascular risk factors and vascular outcomes in type 1 diabetic patients?
In type 1 diabetic patients, adiponectin is inversely associated with renal function and may be elevated as a counterregulatory response to vascular damage.
Schalkwijk et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: